Alzheimer's disease (AD) has no cure, but early detection and risk prediction could allow
earlier intervention. Genetic risk factors may differ between ethnic populations. To discover …

Abstract Introduction Genetic loci for Alzheimer's disease (AD) have been identified in whites
of European ancestry, but the genetic architecture of AD among other populations is less …

Objective Five genomewide association studies (GWAS) in white populations have recently
identified and confirmed 9 novel Alzheimer's disease (AD) susceptibility loci (CLU, CR1 …

Genome-wide association studies (GWAS) have uncovered over two dozen candidate
Alzheimer disease susceptibility genes; however, the results of these studies showed limited …

A large fraction of genetic risk factors for Alzheimer's Disease (AD) is still not identified,
limiting the understanding of AD pathology and study of therapeutic targets. We conducted a …

Genome-wide association studies (GWAS) have gained considerable momentum over the
last couple of years for the identification of novel complex disease genes. In the field of …

While genome wide association studies (GWASs) of Alzheimer's Disease (AD) in European
(EUR) ancestry cohorts have identified approximately 83 potentially independent AD risk …

Recent genome-wide association studies (GWAS) have discovered several Alzheimer
disease (AD) susceptibility loci. However, the identified susceptibility loci are substantially …

Genome-wide association studies (GWAS) of Alzheimer's disease are predominantly carried
out in European ancestry individuals despite the known variation in genetic architecture and …

As the size of genome-wide association studies increase, the number of associated trait loci
identified inevitably increase. One welcomes this if it allows the better delineation of the …